Galectins: Guardians of eutherian pregnancy at the maternal-fetal interface

Trends in Endocrinology and Metabolism

Volumn 23, Issue 1, 2012, Pages 23-31

  Than, Nandor Gabor ^a,b,c   Romero, Roberto ^a   Kim, Chong Jai ^a,b   McGowen, Michael R ^b   Papp, Zoltan ^c   Wildman, Derek E ^a,b  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

ECALECTIN; ESTROGEN; GALECTIN; GALECTIN 1; GALECTIN 10; GALECTIN 12; GALECTIN 13; GALECTIN 14; GALECTIN 15; GALECTIN 16; GALECTIN 17; GALECTIN 19; GALECTIN 2; GALECTIN 20; GALECTIN 3; GALECTIN 4; GALECTIN 5; GALECTIN 6; GALECTIN 7; GALECTIN 8; HSPC159 PROTEIN; MESSENGER RNA; PROGESTERONE; PROGESTERONE DERIVATIVE; PROGESTERONE INDUCED BLOCKING FACTOR; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; APOPTOSIS; BLASTOCYST; CALCIUM SIGNALING; CARBOXY TERMINAL SEQUENCE; CELL DIFFERENTIATION; CELL GROWTH; CELL INTERACTION; CELL MIGRATION; CELLULAR DISTRIBUTION; CELLULAR STRESS RESPONSE; CRYSTALLIZATION; CYTOPLASM; DECIDUA; ENDOMETRIUM; ENDOMETRIUM CELL; EPITHELIUM CELL; EXTRAVILLOUS TROPHOBLAST CELL; FETUS MEMBRANE; FETUS WASTAGE; FIRST TRIMESTER PREGNANCY; GENE EXPRESSION; HELLP SYNDROME; HUMAN; IMMUNOLOGICAL TOLERANCE; MENSTRUAL CYCLE; MESENCHYME CELL; METASTASIS; MOTHER FETUS RELATIONSHIP; NATURAL KILLER CELL; NONHUMAN; PLACENTAL MAMMALS; PREECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATION; PRIORITY JOURNAL; PROTEIN CROSS LINKING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REGULATORY T LYMPHOCYTE; REVIEW; SHORT TANDEM REPEAT; SYNCYTIOTROPHOBLAST; TUMOR ESCAPE; TUMOR GROWTH; TUMOR VASCULARIZATION; UPREGULATION; VILLOUS TROPHOBLAST;

ANIMALS; FEMALE; FETAL PROTEINS; GALECTINS; GLYCOSYLATION; HUMANS; MAMMALS; MATERNAL-FETAL EXCHANGE; PLACENTATION; PREGNANCY; PREGNANCY MAINTENANCE; PREGNANCY PROTEINS; PROTEIN PROCESSING, POST-TRANSLATIONAL;

EID: 84855249936     PISSN: 10432760     EISSN: 18793061     Source Type: Journal    
DOI: 10.1016/j.tem.2011.09.003     Document Type: Review

References (84)

1. Apweiler R., et al. On the frequency of protein glycosylation, as deduced from analysis of the SWISS-PROT database. Biochim. Biophys. Acta 1999, 1473:4-8.
2. Varki A., et al. Essentials in Glycobiology 2008, Cold Spring Harbor Laboratory Press.
3. Gabius H.J., et al. The sugar code: functional lectinomics. Biochim. Biophys. Acta 2002, 1572:165-177.
4. Barondes S.H. Bifunctional properties of lectins: lectins redefined. Trends Biochem. Sci. 1988, 13:480-482.
5. Jones C.J., Aplin J.D. Glycosylation at the fetomaternal interface: does the glycocode play a critical role in implantation?. Glycoconj. J. 2009, 26:359-366.
6. Cooper D.N. Galectinomics: finding themes in complexity. Biochim. Biophys. Acta 2002, 1572:209-231.
7. Barondes S.H., et al. Galectins. Structure and function of a large family of animal lectins. J. Biol. Chem. 1994, 269:20807-20810.
8. Hirabayashi J., Kasai K. The family of metazoan metal-independent beta-galactoside-binding lectins: structure, function and molecular evolution. Glycobiology 1993, 3:297-304.
9. Kasai K., Hirabayashi J. Galectins: a family of animal lectins that decipher glycocodes. J. Biochem. (Tokyo) 1996, 119:1-8.
10. Cummings R.D., Liu F.T. Galectins. Essentials of Glycobiology 2009, 475-488. Cold Spring Harbor Laboratory Press. 2nd edn. A. Varki (Ed.).
11. Blois S.M., et al. A pivotal role for galectin-1 in fetomaternal tolerance. Nat. Med. 2007, 13:1450-1457.
12. Rabinovich G.A., Toscano M.A. Turning 'sweet' on immunity: galectin-glycan interactions in immune tolerance and inflammation. Nat. Rev. Immunol. 2009, 9:338-352.
13. Sato S., et al. Galectins in innate immunity: dual functions of host soluble beta-galactoside-binding lectins as damage-associated molecular patterns (DAMPs) and as receptors for pathogen-associated molecular patterns (PAMPs). Immunol. Rev. 2009, 230:172-187.
14. Liu F.T., Rabinovich G.A. Galectins: regulators of acute and chronic inflammation. Ann. N. Y. Acad. Sci. 2010, 1183:158-182.
15. Than N.G., et al. A primate subfamily of galectins expressed at the maternal-fetal interface that promote immune cell death. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:9731-9736.
16. Than N.G., et al. Emergence of hormonal and redox regulation of galectin-1 in placental mammals: implication in maternal-fetal immune tolerance. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:15819-15824.
17. Lewis S.K., et al. Galectin 15 (LGALS15): a gene uniquely expressed in the uteri of sheep and goats that functions in trophoblast attachment. Biol. Reprod. 2007, 77:1027-1036.
18. Than N.G., et al. Functional analyses of placental protein 13/galectin-13. Eur. J. Biochem. 2004, 271:1065-1078.
19. Choe Y.S., et al. Expression of galectin-1 mRNA in the mouse uterus is under the control of ovarian steroids during blastocyst implantation. Mol. Reprod. Dev. 1997, 48:261-266.
20. Vicovac L., et al. Galectin-1 and -3 in cells of the first trimester placental bed. Hum. Reprod. 1998, 13:730-735.
21. Than N.G., et al. Isolation and sequence analysis of a cDNA encoding human placental tissue protein 13 (PP13), a new lysophospholipase, homologue of human eosinophil Charcot-Leyden crystal protein. Placenta 1999, 20:703-710.
22. Koopman L.A., et al. Human decidual natural killer cells are a unique NK cell subset with immunomodulatory potential. J. Exp. Med. 2003, 198:1201-1212.
23. Bozic M., et al. Galectin-1 and galectin-3 in the trophoblast of the gestational trophoblastic disease. Placenta 2004, 25:797-802.
24. Popovici R.M., et al. Galectin-9: a new endometrial epithelial marker for the mid- and late-secretory and decidual phases in humans. J. Clin. Endocrinol. Metab. 2005, 90:6170-6176.
25. von Wolff M., et al. Galectin fingerprinting in human endometrium and decidua during the menstrual cycle and in early gestation. Mol. Hum. Reprod. 2005, 11:189-194.
26. Liu A.X., et al. Proteomic analysis on the alteration of protein expression in the placental villous tissue of early pregnancy loss. Biol. Reprod. 2006, 75:414-420.
27. Jeschke U., et al. Expression of galectin-1, -3 (gal-1, gal-3) and the Thomsen-Friedenreich (TF) antigen in normal, IUGR, preeclamptic and HELLP placentas. Placenta 2007, 28:1165-1173.
28. Kopcow H.D., et al. T cell apoptosis at the maternal-fetal interface in early human pregnancy, involvement of galectin-1. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:18472-18477.
29. Than N.G., et al. Placental protein 13 (galectin-13) has decreased placental expression but increased shedding and maternal serum concentrations in patients presenting with preterm pre-eclampsia and HELLP syndrome. Virchows Arch. 2008, 453:387-400.
30. Than N.G., et al. Chorioamnionitis and increased galectin-1 expression in PPROM -an anti-inflammatory response in the fetal membranes?. Am. J. Reprod. Immunol. 2008, 60:298-311.
31. Than N.G., et al. Severe preeclampsia is characterized by increased placental expression of galectin-1. J. Matern. Fetal Neonatal Med. 2008, 21:429-442.
32. Sekizawa A., et al. PP13 mRNA expression in trophoblasts from preeclamptic placentas. Reprod. Sci. 2009, 16:408-413.
33. Winn V.D., et al. Severe preeclampsia-related changes in gene expression at the maternal-fetal interface include sialic acid-binding immunoglobulin-like lectin-6 and pappalysin-2. Endocrinology 2009, 150:452-462.
34. Nhan-Chang C.L., et al. Characterization of the transcriptome of chorioamniotic membranes at the site of rupture in spontaneous labor at term. Am. J. Obstet. Gynecol. 2010, 202:462-541.
35. Shankar R., et al. Molecular markers of preterm labor in the choriodecidua. Reprod. Sci. 2010, 17:297-310.
36. Kolundzic N., et al. Galectin-8 is expressed by villous and extravillous trophoblast of the human placenta. Placenta 2011, 10.1016/j.placenta.2011.07.087.
37. Balogh A., et al. Placental protein 13 (PP13/galectin-13) undergoes lipid raft-associated subcellular redistribution in the syncytiotrophoblast in preterm preeclampsia and HELLP syndrome. Am. J. Obstet. Gynecol. 2011, 205:156.e1-156.e14.
38. Kliman H.J., et al. Placental protein 13 and decidual zones of necrosis: an immunologic diversion that may be linked to preeclampsia. Reprod. Sci. 2011, 10.1177/1933719111424445.
39. Than N.G., et al. PP13, maternal ABO blood groups and the risk assessment of pregnancy complications. PLoS ONE 2011, 6:e21564.
40. Burger O., et al. Placental protein 13 (PP-13): effects on cultured trophoblasts, and its detection in human body fluids in normal and pathological pregnancies. Placenta 2004, 25:608-622.
41. Nicolaides K.H., et al. A novel approach to first-trimester screening for early pre-eclampsia combining serum PP-13 and Doppler ultrasound. Ultrasound Obstet. Gynecol. 2006, 27:13-17.
42. Chafetz I., et al. First-trimester placental protein 13 screening for preeclampsia and intrauterine growth restriction. Am. J. Obstet. Gynecol. 2007, 197:35-37.
43. Spencer K., et al. First-trimester maternal serum PP-13, PAPP-A and second-trimester uterine artery Doppler pulsatility index as markers of pre-eclampsia. Ultrasound Obstet. Gynecol. 2007, 29:128-134.
44. Huppertz B., et al. Longitudinal determination of serum placental protein 13 during development of preeclampsia. Fetal Diagn. Ther. 2008, 24:230-236.
45. Gonen R., et al. Placental protein 13 as an early marker for pre-eclampsia: a prospective longitudinal study. BJOG 2008, 115:1465-1472.
46. Romero R., et al. First-trimester maternal serum PP13 in the risk assessment for preeclampsia. Am. J. Obstet. Gynecol. 2008, 199:122.
47. Akolekar R., et al. Maternal serum placental protein 13 at 11-13 weeks of gestation in preeclampsia. Prenat. Diagn. 2009, 29:1103-1108.
48. Khalil A., et al. First-trimester markers for the prediction of pre-eclampsia in women with a-priori high risk. Ultrasound Obstet. Gynecol. 2010, 35:671-679.
49. Wortelboer E.J., et al. First-trimester placental protein 13 and placental growth factor: markers for identification of women destined to develop early-onset pre-eclampsia. BJOG 2010, 117:1384-1389.
50. Molvarec A., et al. Peripheral blood galectin-1-expressing T and natural killer cells in normal pregnancy and preeclampsia. Clin. Immunol. 2011, 139:48-56.
51. Houzelstein D., et al. Phylogenetic analysis of the vertebrate galectin family. Mol. Biol. Evol. 2004, 21:1177-1187.
52. Brewer F.C. Binding and cross-linking properties of galectins. Biochim. Biophys. Acta 2002, 1572:255-262.
53. Swaminathan G.J., et al. Selective recognition of mannose by the human eosinophil Charcot-Leyden crystal protein (galectin-10): a crystallographic study at 1.8Å resolution. Biochemistry 1999, 38:13837-13843.
54. Visegrady B., et al. Homology modelling and molecular dynamics studies of human placental tissue protein 13 (galectin-13). Protein Eng. 2001, 14:875-880.
55. Lopez-Lucendo M.F., et al. Growth-regulatory human galectin-1: crystallographic characterisation of the structural changes induced by single-site mutations and their impact on the thermodynamics of ligand binding. J. Mol. Biol. 2004, 343:957-970.
56. Horlacher T., et al. Determination of carbohydrate-binding preferences of human galectins with carbohydrate microarrays. Chembiochem 2010, 11:1563-1573.
57. Stowell S.R., et al. Innate immune lectins kill bacteria expressing blood group antigen. Nat. Med. 2010, 16:295-301.
58. Liu F.T., et al. Intracellular functions of galectins. Biochim. Biophys. Acta 2002, 1572:263-273.
59. Camby I., et al. Galectin-1: a small protein with major functions. Glycobiology 2006, 16:137-157.
60. Hernandez J.D., Baum L.G. Ah, sweet mystery of death! Galectins and control of cell fate. Glycobiology 2002, 12:127R-136R.
61. Nickel W. Unconventional secretory routes: direct protein export across the plasma membrane of mammalian cells. Traffic 2005, 6:607-614.
62. Danielsen E.M., Hansen G.H. Lipid raft organization and function in brush borders of epithelial cells. Mol. Membr. Biol. 2006, 23:71-79.
63. Dennis J.W., et al. Metabolism, cell surface organization, and disease. Cell 2009, 139:1229-1241.
64. Bianchi M.E. DAMPs, PAMPs and alarmins: all we need to know about danger. J. Leukoc. Biol. 2007, 81:1-5.
65. Su A.I., et al. A gene atlas of the mouse and human protein-encoding transcriptomes. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:6062-6067.
66. Saal I., et al. Human galectin-2: expression profiling by RT-PCR/immunohistochemistry and its introduction as a histochemical tool for ligand localization. Histol. Histopathol. 2005, 20:1191-1208.
67. Dong M., et al. The effect of trophoblasts on T lymphocytes: possible regulatory effector molecules - a proteomic analysis. Cell Physiol. Biochem. 2008, 21:463-472.
68. Gitt M.A., et al. Galectin-4 and galectin-6 are two closely related lectins expressed in mouse gastrointestinal tract. J. Biol. Chem. 1998, 273:2954-2960.
69. Kubach J., et al. Human CD4+CD25+ regulatory T cells: proteome analysis identifies galectin-10 as a novel marker essential for their anergy and suppressive function. Blood 2007, 110:1550-1558.
70. Yang Q.S., et al. Cloning and expression of a novel human galectin cDNA, predominantly expressed in placenta(1). Biochim. Biophys. Acta 2002, 1574:407-411.
71. Young A.R., et al. Functional characterization of an eosinophil-specific galectin, ovine galectin-14. Glycoconj. J. 2009, 26:423-432.
72. Bischof P., Irminger-Finger I. The human cytotrophoblastic cell, a mononuclear chameleon. Int. J Biochem. Cell Biol. 2005, 37:1-16.
73. Rabinovich G.A., Ilarregui J.M. Conveying glycan information into T-cell homeostatic programs: a challenging role for galectin-1 in inflammatory and tumor microenvironments. Immunol. Rev. 2009, 230:144-159.
74. Garin M.I., et al. Galectin-1: a key effector of regulation mediated by CD4+CD25+ T cells. Blood 2007, 109:2058-2065.
75. Moffett A., Loke C. Immunology of placentation in eutherian mammals. Nat. Rev. Immunol. 2006, 6:584-594.
76. Aluvihare V.R., et al. Regulatory T cells mediate maternal tolerance to the fetus. Nat. Immunol. 2004, 5:266-271.
77. Redman C.W., Sargent I.L. Immunology of pre-eclampsia. Am. J. Reprod. Immunol. 2010, 63:534-543.
78. Elola M.T., et al. Galectin-1 receptors in different cell types. J. Biomed. Sci. 2005, 12:13-29.
79. Aplin J.D. Developmental cell biology of human villous trophoblast: current research problems. Int. J. Dev. Biol. 2010, 54:323-329.
80. Gebhardt S., et al. A novel exonic variant (221delT) in the LGALS13 gene encoding placental protein 13 (PP13) is associated with preterm labour in a low risk population. J. Reprod. Immunol. 2009, 82:166-173.
81. Romero R. Prenatal medicine: the child is the father of the man. Prenat. Neonatal Med. 1996, 1:8-11.
82. Wildman D.E, et al. Evolution of the mammalian placenta revealed by phylogenetic analysis. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:3203-3208.
83. Lynch M., Force A. The probability of duplicate gene preservation by subfunctionalization. Genetics 2000, 154:459-473.
84. Inagaki Y., et al. Oxidized galectin-1 promotes axonal regeneration in peripheral nerves but does not possess lectin properties. Eur. J. Biochem. 2000, 267:2955-2964.